首页> 外文OA文献 >Hazard rate of tumor recurrence over time: a pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC)

【2h】

Hazard rate of tumor recurrence over time: a pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC)

机译：随着时间的推移肿瘤复发的危害率：通过日本癌症的多学科治疗基础的基于氟嘧啶的佐剂化疗的三种临床试验的汇总分析（JFMC）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hiromichi Maeda; Koji Oba; Chikuma Hamada; Sotaro Sadahiro; Toru Aoyama; Michitaka Honda; Shuhei Mayanagi; Kosuke Kashiwabara; Junichi Sakamoto; Shigetoyo Saji; Takaki Yoshikawa;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Hazard rate of tumor recurrence over time: a pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) [J] . Hiromichi Maeda, Koji Oba, Chikuma Hamada, Annals of Cancer Research and Therapy . 2016,第2期

机译：随着时间的推移，肿瘤复发的危险率：日本多学科癌症基金会（JFMC）对基于氟嘧啶的大肠癌辅助化疗的三项临床试验的汇总分析
2. Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials [J] . Hiromichi Maeda, Kosuke Kashiwabara, Toru Aoyama, Journal of Cancer . 2017,第19期

机译：结肠癌患者随时间推移的肿瘤复发危险率：对三项日本多学科癌症治疗基金会（JFMC）临床试验的术后监测的意义
3. A randomized phase III study of hepatic arterial infusion chemotherapy with 5-fluorouracil and subsequent systemic chemotherapy versus systemic chemotherapy alone for colorectal cancer patients with curatively resected liver metastases (Japanese Foundation for Multidisciplinary Treatment of Cancer 32) [J] . Mitsuo Kusano, Toru Aoyama, Koji Okabayashi, Journal of Cancer Research and Therapeutics . 2018,第10期

机译：肝动脉灌注化疗联合5-氟尿嘧啶及其后全身化疗与全身化疗的随机III期研究，用于结直肠癌肝转移治愈的大肠癌患者（日本癌症多学科治疗基金会32）
4. Assessing the population representativeness of colorectal cancer treatment clinical trials [C] . Zhe He, Zhiwei Chen, Thomas J George, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：评估结直肠癌治疗临床试验的人群代表性
5. Hazard rate of tumor recurrence over time in patients with colon cancer: implications for postoperative surveillance from three Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC) clinical trials [O] . Hiromichi Maeda, Kosuke Kashiwabara, Toru Aoyama, 2017

机译：结肠癌患者随着时间推移肿瘤复发的危险率：对三项日本多学科癌症治疗基金会（JFMC）临床试验对术后监测的意义
6. Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201) [O] . Sadahiro Sotaro, Morita Satoshi, Sasaki Kazuaki, 2015

机译：UFT / LV治疗具有复发危险因素的II期大肠癌的临床疗效的治疗原理和研究设计（JFMC46-1201）

Hazard rate of tumor recurrence over time: a pooled-analysis of three clinical trials with fluoropyrimidine-based adjuvant chemotherapy for colorectal cancer achieved by the Japanese Foundation for Multidisciplinary Treatment of Cancer (JFMC)

著录项

相似文献

相关主题

期刊订阅